Factors affecting patient participation in clinical trials in Ireland: A narrative review

Abstract

ObjectiveClinical trials have long been considered the ‘gold standard’ of research generated evidence in health care. Patient recruitment is an important determinant in the success of the trials, yet little focus is placed on the decision making process of patients towards recruitment. Our objective was to identify the key factors pertaining to patient participation in clinical trials, to better understand the identified low participation rate of patients in one clinical research facility within Ireland.DesignNarrative literature review of studies focussing on factors which may act to facilitate or deter patient participation in clinical trials. Studies were identified from Medline, PubMed, Cochrane Library and CINAHL.ResultsSixty-one studies were included in the narrative review: Forty-eight of these papers focused specifically on the patient's perspective of participating in clinical trials. The remaining thirteen related to carers, family and health care professional perspectives of participation. The primary factor influencing participation in clinical trials amongst patients was related to personal factors and these were collectively associated with obtaining a form of personal gain through participation. Cancer was identified as the leading disease entity included in clinical trials followed by HIV and cardiovascular disease.ConclusionThe vast majority of literature relating to participation in clinical trials emanates predominantly from high income countries, with 63% originating from the USA. No studies for inclusion in this review were identified from low income or developing countries and therefore limits the generalizability of the influencing factors.

How Can Experiments Play a Greater Role in Public Policy? 12 Proposals from an Economic Model of Scaling

“…For example, in Cooper et al (2015), recruitment for medical treatments for type 2 diabetes was significantly easier than for prevention interventions, due to the size, tangibility, and immediacy of the effects of the former. While factors such as altruism and the desire to save money are important determinants of an individual's readiness to participate in a medical trial, surveys also indicate that perceived benefits are critical, often because prospective participants assume that the medical treatment in a medical trial is of higher quality than conventional, non-experimental treatment (Walsh and Sheridan, 2016).…”

Attitude of Asian Parkinson Patients towards Clinical Research and Tissue Donation

“…Another factor that may improve participation in research is the concept of providing compensations to the participants. is widely practiced method to enhance enrollment in research may include free clinic visits, free laboratory tests related to research, transport compensations, complimentary parking spaces, gift cards, or cheques [8,18,21]. Two studies from India emphasized poor patient knowledge about their research participation rights as only one-third of the patients were aware of the concept of compensations offered to participants [6,11].…”

A pilot feasibility randomised clinical trial comparing dialkylcarbamoylchloride‐coated dressings versus standard care for the primary prevention of surgical site infection

“…Patients not wishing to take part in research or patients who were unable or unwilling to re‐attend hospital for additional clinical visits made up over half of eligible patients who were subsequently not recruited. Travel problems, and additional appointments or costs to patients, are established barriers to participation in clinical research . Follow‐up procedures for a larger trial would need to be augmented to facilitate recruitment as over 40% of eligible patients not recruited cited such problems as a reason for not entering the trial.…”